fda Archives -

MDMA on track for 2023 approval as PTSD therapy, says developer

https://pharmaphorum.com/news/mdma-on-track-for-2023-approval-as-ptsd-therapy-says-developer/

FDA extends tie-up with CN Bio to test ‘lung-on-a-chip’ tech

https://pharmaphorum.com/news/fda-extends-tie-up-with-cn-bio-to-test-lung-on-a-chip-tech/

Formedix Expedites Clinical Trial Build with New Cloud Clinical MDR Suite

https://pharmaphorum.com/partner-content/formedix-expedites-clinical-trial-build-with-new-cloud-clinical-mdr-suite/

AstraZeneca’s Farxiga claims first SGLT2 kidney disease OK from FDA

https://pharmaphorum.com/news/astrazenecas-farxiga-gets-first-kidney-disease-ok-from-fda/

Keytruda should lose stomach cancer indication, says ODAC

https://pharmaphorum.com/news/keytruda-should-lose-stomach-cancer-indication-says-odac/

FDA sets September review date for Calliditas’ rare kidney disease drug

https://pharmaphorum.com/news/fda-sets-september-review-date-for-calliditas-rare-kidney-disease-drug/

FDA looks at pulling speedy approvals for three cancer drugs

https://pharmaphorum.com/news/fda-looks-at-pulling-speedy-approvals-for-three-cancer-drugs/

FDA lifts hold on uniQure gene therapy after cancer case review

https://pharmaphorum.com/news/fda-lifts-hold-on-uniqure-gene-therapy-after-cancer-case-review/

FDA approves under-pressure GSK’s Jemperli for endometrial cancer

https://pharmaphorum.com/news/fda-approves-under-pressure-gsks-jemperli-for-endometrial-cancer/

Search